GUILLERMO GARCIA-MANERO to Epoetin Alfa
This is a "connection" page, showing publications GUILLERMO GARCIA-MANERO has written about Epoetin Alfa.
Connection Strength
0.332
-
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial. Lancet. 2023 07 29; 402(10399):373-385.
Score: 0.233
-
Hypomethylating agents and other novel strategies in myelodysplastic syndromes. J Clin Oncol. 2011 Feb 10; 29(5):516-23.
Score: 0.099